Skip to content
2000
Volume 10, Issue 13
  • ISSN: 1389-5575
  • E-ISSN: 1875-5607

Abstract

CCR5 (C-C chemokine receptor type 5) is a chemokine receptor that has been identified as a major HIV coreceptor in viral entry and therefore is a highly validated target for the development of new anti-HIV drugs. Here, we discuss the insights gained so far relevant to the development of small-molecule CCR5 inhibitors for the treatment of HIV, and highlight small-molecule CCR5 inhibitors that are currently under preclinical and clinical trials.

Loading

Article metrics loading...

/content/journals/mrmc/10.2174/138955710793177269
2010-11-01
2025-10-27
Loading full text...

Full text loading...

/content/journals/mrmc/10.2174/138955710793177269
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test